Treatments
Programme
Results
Experts
Resources
product-image
product-image

Wegovy is a weekly weight loss injection containing semaglutide that can help you lose up to 20.7% of your body weight.

Get more from Wegovy with Voy

Personalised coaching, expert support, and a dedicated side effects support line to help you go further.

  • 0.25mg
    £142.80
  • 0.5mg
    £179
  • 1mg
    £189
  • 1.7mg
    £219
  • 2.4mg
    £239
clinician

“Only patients who are currently on the medication or have recently been on it can start on a higher dose"

Dr Earim Chaudry, Chief Medical Officer
Save 25% on your first month
£109.00 for month 1 of your plan
From £142,80 per month thereafter, your dose and price will increase in line with your treatment plan
iconCancel any time plans
Trustpilot
icon
icon

UK Licensed medication

icon
icon

Free next-day delivery

icon
icon

Cancel anytime subscription

icon
icon

Ongoing medical support

icon
icon

UK Licensed medication

icon
icon

Free next-day delivery

icon
icon

Cancel anytime subscription

icon
icon

Ongoing medical support

About Wegovy

What is Wegovy?

Wegovy is a UK-licensed prescription medication that contains the active ingredient semaglutide, a clinically proven treatment for long-term weight loss.

It works by mimicking a natural gut hormone called GLP-1, which helps regulate hunger, reduce cravings, and promote a feeling of fullness after eating. This makes it easier to adopt healthier habits and stick to them over

Wegovy is taken once a week as an injection. The dose is gradually increased to help your body adjust and reduce the risk of side effects, continuing until you reach the dose that works best for you.

In clinical trials, people taking the highest approved dose of Wegovy — alongside lifestyle changes — lost an average of 20.7% of their body weight over 72 weeks.

Voy members lose on average
icon
21.55%
body weight in 10 months
Based on a clinical study of  57,975 VOY participants in partnership with Imperial College London
https://www.jmir.org/2025/1/e69466
See how much weight you could lose
95kg
On the Voy programme you could lose
20.5kg
Safety

Is Wegovy safe?

Wegovy is MHRA-approved and is considered safe for weight loss when used under medical supervision. You might experience side-effects like nausea, vomiting, constipation or fatigue, especially at the start, but these are usually mild and typically clear up on their own over time.

Wegovy pricing

If you’re currently using Wegovy (or have recently used it) you can buy the Wegovy step-up or maintenance dose through Voy.

Treatment starts with a low initial dose, which can be gradually increased every four weeks based on your progress.

0.25mg
£142.80
0.5mg
£179
1mg
£189
1.7mg
£219
2.4mg
£239

Led by the country’s leading obesity experts

clinician image

Dr. Earim Chaudry is a highly accomplished digital health doctor with extensive experience in the field of online and telemedicine-based healthcare. Over the years, he has played a pivotal role in shaping the landscape of digital healthcare in the UK.

Earim Chaudry, MBBS

Chief Medical Officer

clinician image

Anna is a health behaviour change expert and nutritionist with 15 years of experience in coaching. She is the driving force behind the integration of behaviour change psychology into our programme.

Anna Mullany, MSc, BSc

Head of Behaviour Change

clinician image

At the nutritional helm is Molly Morgan, whose career spans various industries including the NHS, pharmaceutical trials and digital health technology start-ups.

Molly Morgan, RD

Lead Dietitian

In partnership with leading educational and research institutions

The process

How to order Wegovy

  • 1

    Complete our questionnaire

    Take our online assessment to find out if Wegovy is right for you.

  • 2

    Get started

    Once you’ve completed our safety checks, start your journey.

  • 3

    Receive your treatment

    We’ll deliver your Wegovy discreetly to your door.

Our members experience transformational results
5x

Participants on the Voy programme lost 5 times more weight than with diet and exercise alone.

chart

Wegovy FAQ

Dr Earim Chaudry (MBBS), Chief Medical Officer

Medically reviewed on July 30th, 2025.
References
icon¹

STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo, January 17, 2025. https://www.appliedclinicaltrialsonline.com/view/step-up-trial-semaglutide-superior-weight-loss

icon²

Moiz, Areesha et al., “Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”, The American Journal of Cardiology, Volume 222, 2024, 112-130. pubmed.ncbi.nlm.nih.gov/38679221/

icon³

“Wegovy: Package Leaflet, Information for the Patient.” Electronic Medicines Compendium. www.medicines.org.uk/emc/files/pil.13800.pdf. Accessed 9 Dec 2024.

icon

Fornes, Abby, et al. “Once-Weekly Semaglutide For Weight Management: A Clinical Review.” Journal of Pharmacy Technology, vol. 38, no. 4, 2022,pp 239-246. https://doi.org/10.1177/87551225221092681.

icon

National Institute for Health and Care Excellence. “Semaglutide For Managing Overweight And Obesity.” Clinical Guidance, NICE (2023). Accessed 4 Dec. 2024. www.nice.org.uk/guidance/ta875/resources/semaglutide-for-managing-overweight-and-obesity-pdf-82613674831813.

icon

Smits, Mark M., and Daniël H. Van Raalte. “Safety of Semaglutide.” Frontiers in Endocrinology, vol. 12, 2021, article 645563. pmc.ncbi.nlm.nih.gov/articles/PMC8294388/.

Your first step towards weight loss starts here

Today can be life changing

Take the first step towards weight loss that lasts.